FDANonrulemakingFDA-2017-D-2802

Who commented on this docket

CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports

1 organizations filed 1 public comment on CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports, at the Food and Drug Administration. The comment window closed 3213d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 3213d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports (FDA-2017-D-2802) | OpenPolis